CovidChloroV1, Main, Corpus, bibRecord, 001346

Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.

Identifieur interne : 001346 ( Main/Corpus ); précédent : 001345; suivant : 001347

Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.

Auteurs : Vidya M. Mahalmani ; Dhruv Mahendru ; Phulen Sarma ; Ajay Prakash ; Bikash Medhi

Source :

Indian journal of pharmacology [ 1998-3751 ]

RBID : pubmed:32565593

English descriptors

KwdEn :
- Angiotensin-Converting Enzyme Inhibitors (adverse effects), Angiotensin-Converting Enzyme Inhibitors (therapeutic use), Antimalarials (therapeutic use), COVID-19 (MeSH), Chloroquine (adverse effects), Chloroquine (therapeutic use), Coronavirus Infections (drug therapy), Coronavirus Infections (prevention & control), Drug Delivery Systems (MeSH), Humans (MeSH), Hydroxychloroquine (adverse effects), Hydroxychloroquine (therapeutic use), Ibuprofen (adverse effects), Ibuprofen (therapeutic use), Pandemics (prevention & control), Pneumonia, Viral (drug therapy), Pneumonia, Viral (prevention & control), Treatment Outcome (MeSH).
MESH :
- chemical , adverse effects : Angiotensin-Converting Enzyme Inhibitors, Chloroquine, Hydroxychloroquine, Ibuprofen.
- chemical , therapeutic use : Angiotensin-Converting Enzyme Inhibitors, Antimalarials, Chloroquine, Hydroxychloroquine, Ibuprofen.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- COVID-19, Drug Delivery Systems, Humans, Treatment Outcome.

DOI: 10.4103/ijp.IJP_309_20
PubMed: 32565593
PubMed Central: PMC7282682

Links to Exploration step

pubmed:32565593

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.</title>
<author><name sortKey="Mahalmani, Vidya M" sort="Mahalmani, Vidya M" uniqKey="Mahalmani V" first="Vidya M" last="Mahalmani">Vidya M. Mahalmani</name>
<affiliation><nlm:affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mahendru, Dhruv" sort="Mahendru, Dhruv" uniqKey="Mahendru D" first="Dhruv" last="Mahendru">Dhruv Mahendru</name>
<affiliation><nlm:affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sarma, Phulen" sort="Sarma, Phulen" uniqKey="Sarma P" first="Phulen" last="Sarma">Phulen Sarma</name>
<affiliation><nlm:affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Prakash, Ajay" sort="Prakash, Ajay" uniqKey="Prakash A" first="Ajay" last="Prakash">Ajay Prakash</name>
<affiliation><nlm:affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Medhi, Bikash" sort="Medhi, Bikash" uniqKey="Medhi B" first="Bikash" last="Medhi">Bikash Medhi</name>
<affiliation><nlm:affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020 Mar-Apr</date>
<idno type="RBID">pubmed:32565593</idno>
<idno type="pmid">32565593</idno>
<idno type="doi">10.4103/ijp.IJP_309_20</idno>
<idno type="pmc">PMC7282682</idno>
<idno type="wicri:Area/Main/Corpus">001346</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001346</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.</title>
<author><name sortKey="Mahalmani, Vidya M" sort="Mahalmani, Vidya M" uniqKey="Mahalmani V" first="Vidya M" last="Mahalmani">Vidya M. Mahalmani</name>
<affiliation><nlm:affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mahendru, Dhruv" sort="Mahendru, Dhruv" uniqKey="Mahendru D" first="Dhruv" last="Mahendru">Dhruv Mahendru</name>
<affiliation><nlm:affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sarma, Phulen" sort="Sarma, Phulen" uniqKey="Sarma P" first="Phulen" last="Sarma">Phulen Sarma</name>
<affiliation><nlm:affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Prakash, Ajay" sort="Prakash, Ajay" uniqKey="Prakash A" first="Ajay" last="Prakash">Ajay Prakash</name>
<affiliation><nlm:affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Medhi, Bikash" sort="Medhi, Bikash" uniqKey="Medhi B" first="Bikash" last="Medhi">Bikash Medhi</name>
<affiliation><nlm:affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Indian journal of pharmacology</title>
<idno type="eISSN">1998-3751</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Angiotensin-Converting Enzyme Inhibitors (adverse effects)</term>
<term>Angiotensin-Converting Enzyme Inhibitors (therapeutic use)</term>
<term>Antimalarials (therapeutic use)</term>
<term>COVID-19 (MeSH)</term>
<term>Chloroquine (adverse effects)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Drug Delivery Systems (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (adverse effects)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Ibuprofen (adverse effects)</term>
<term>Ibuprofen (therapeutic use)</term>
<term>Pandemics (prevention & control)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Angiotensin-Converting Enzyme Inhibitors</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
<term>Ibuprofen</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Angiotensin-Converting Enzyme Inhibitors</term>
<term>Antimalarials</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
<term>Ibuprofen</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Drug Delivery Systems</term>
<term>Humans</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32565593</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1998-3751</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>52</Volume>
<Issue>2</Issue>
<PubDate><MedlineDate>2020 Mar-Apr</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Indian journal of pharmacology</Title>
<ISOAbbreviation>Indian J Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.</ArticleTitle>
<Pagination><MedlinePgn>75-78</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4103/ijp.IJP_309_20</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mahalmani</LastName>
<ForeName>Vidya M</ForeName>
<Initials>VM</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mahendru</LastName>
<ForeName>Dhruv</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sarma</LastName>
<ForeName>Phulen</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Prakash</LastName>
<ForeName>Ajay</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Medhi</LastName>
<ForeName>Bikash</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology, PGIMER, Chandigarh, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>06</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>India</Country>
<MedlineTA>Indian J Pharmacol</MedlineTA>
<NlmUniqueID>7902477</NlmUniqueID>
<ISSNLinking>0253-7613</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>WK2XYI10QM</RegistryNumber>
<NameOfSubstance UI="D007052">Ibuprofen</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016503" MajorTopicYN="N">Drug Delivery Systems</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007052" MajorTopicYN="N">Ibuprofen</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>04</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>6</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>6</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32565593</ArticleId>
<ArticleId IdType="doi">10.4103/ijp.IJP_309_20</ArticleId>
<ArticleId IdType="pii">IJPharm-52-75</ArticleId>
<ArticleId IdType="pmc">PMC7282682</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14408-14413</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27911847</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2012 May 17;366(20):1881-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22591294</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Med. 1983 Jul 18;75(1A):40-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6869410</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Biomed. 2006 Apr;77(1):30-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16856707</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Rheum. 2002 Jun;46(6):1460-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12115175</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2020 Mar 17;94(7):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31996437</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Mar 09;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pharm Pract. 2014 Oct;27(5):496-500</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25374989</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jan 1;1072:320-327</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29207305</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci China Life Sci. 2020 Mar;63(3):364-374</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32048163</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 Apr;8(4):e21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32171062</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Chem. 2006 May 4;49(9):2845-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16640347</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 1996 Mar;55(3):187-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8712882</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>ACS Infect Dis. 2015 Jul 10;1(7):317-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27622822</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2001 Feb;20(3):137-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11166662</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1991 Dec;65(12):7008-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1658391</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2014 Feb 22;383(9918):723-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23953767</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Mar 20;:105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Rheumatol. 2020 Mar;16(3):155-166</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32034323</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care. 2017 Sep 7;21(1):234</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28877748</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2007 Oct;30(4):297-308</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17629679</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Hepatol. 2013 Nov-Dec;12(6):892-900</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24114819</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Rep. 2016 Jun 28;6:28698</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27350308</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Pharmacol. 2015 Feb 1;93(3):343-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25482567</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32253318</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2001 Sep 15;184(6):770-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11517439</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2015 Nov 17;314(19):2034-2044</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26575060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2003 Nov;3(11):722-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14592603</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001346 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001346 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32565593
   |texte=   Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32565593" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.

Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki